.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Accenture
Chinese Patent Office
Dow
UBS
Fuji
Moodys
Harvard Business School
AstraZeneca
Teva

Generated: June 27, 2017

DrugPatentWatch Database Preview

Shire Company Profile

« Back to Dashboard

Summary for Applicant: Shire

Patents:5
Tradenames:1
Ingredients:1
BLAs:1
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Shire
ELAPRASE
idursulfase
INJECTABLE; IV (INFUSION)1251510012006-07-248,277,830 ForSight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (Menlo Park, CA), Alster; Yair (Menlo Park, CA), Farinas; Kathleen Cogan (Menlo Park, CA), Gifford, III; Hanson S. (Menlo Park, CA), MacFarlane; K. Angela (Menlo Park, CA), Reich; Cary J. (Menlo Park, CA), Barrett; Michael (Menlo Park, CA), Campbell; Randolph E. (Menlo Park, CA), Sutton; Douglas (Menlo Park, CA) ► SubscribeRXOrphansearch
Shire
ELAPRASE
idursulfase
INJECTABLE; IV (INFUSION)1251510012006-07-248,399,006 Forsight Vision4, Inc. (Menlo Park, CA) de Juan, Jr.; Eugene (San Francisco, CA), Alster; Yair (Palo Alto, CA), Chamow; Steven M. (San Mateo, CA), Farinas; Kathleen Cogan (Los Altos, CA), Gifford, III; Hanson S. (Woodside, CA), Macfarlane; K. Angela (Woodside, CA), Reich; Cary J. (Los Gatos, CA), Barrett; Michael (Cupertino, CA), Campbell; Randolph E. (Redwood City, CA), George; Robert (San Jose, CA), Sutton; Douglas (Pacifica, CA) ► SubscribeRXOrphansearch
Shire
ELAPRASE
idursulfase
INJECTABLE; IV (INFUSION)1251510012006-07-249,075,057 Shire Human Genetic Therapies, Inc. (Lexington, MA) Roseman; Daniel S. (Framingham, MA) ► SubscribeRXOrphansearch
Shire
ELAPRASE
idursulfase
INJECTABLE; IV (INFUSION)1251510012006-07-249,554,968 SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) Weikart; Christopher (Auburn, AL), Clark; Becky L. (Auburn, AL), Stevenson; Adam (Opelika, AL), Felts; John T. (Alameda, CA) ► SubscribeRXOrphansearch
Shire
ELAPRASE
idursulfase
INJECTABLE; IV (INFUSION)1251510012006-07-249,562,904 Shire Human Genetic Therapies, Inc. (Lexington, MA) Roseman; Daniel S. (Framingham, MA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
McKinsey
Federal Trade Commission
Johnson and Johnson
UBS
Cipla
Chubb
Accenture
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot